Nonalcoholic fatty liver disease (NAFLD) – is it a new risk factor for adverse cardiovascular events in haemodialysis patients? (CROSBI ID 614980)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | domaća recenzija
Podaci o odgovornosti
Mikolašević, Ivana ; Lukenda, Vesna ; Rački, Sanjin ; Anić, Kata ; Zaputović, Luka ; Milić, Sandra ; Štimac, Davor ; Orlić, Lidija
engleski
Nonalcoholic fatty liver disease (NAFLD) – is it a new risk factor for adverse cardiovascular events in haemodialysis patients?
Background/Aims: Cardiovascular diseases (CVD) are the leading cause of mortality in hemodialysis (HD) patients. Recently, non-alcoholic fatty liver disease (NAFLD) has been recognized as a new risk factor for adverse CVD events in the general population. Our aim was to analyze the incidence of NAFLD in HD patients by using transient elastography and to analyze whether the presence of NAFLD is associated with a higher CVD risk in HD patients. Methods: The subjects were 72 HD patients and 50 sex- and age-matched controls. Results: NAFLD was found in 52.8% of HD patients. HD patients with NAFLD showed more carotid atherosclerosis and more adverse CVD events than HD patients without NAFLD and control subjects. Conclusion: We showed for the first time that HD patients have a high prevalence of NAFLD. HD patients with NAFLD show an advanced carotid atherosclerosis. Detection of NAFLD by transient elastography should alert to the existence of an increased cardiovascular risk in HD patients
Cardiovascular diseases; Nonalcoholic fatty liver disease; Haemodialysis
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
20-20.
2014.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora
Branimir Anić
Zagreb:
0024-3477
Podaci o skupu
8.Hrvatski Internistički Kongres s međunarodnim sudjelovanjem
poster
03.10.2014-05.10.2014
Opatija, Hrvatska